What’s Going On With Exela Technologies Stock Today?

Exela Technologies Inc (NASDAQ: XELA) shares are trading higher by 6.92% to $0.40, but off the session high of $0.49, after the company announced its European business will go public through a merger with CF Acquisition Corp.

Exela Technologies Inc (NASDAQ:XELA) shares are trading higher by 6.92% to $0.40, but off the session high of $0.49, after the company announced its European business will go public through a merger with CF Acquisition Corp. VIII (NASDAQ:CFFE).

What Else?

After closing, the combined company will be called XBP Europe Holdings, Inc. and is expected to be publicly listed on Nasdaq under the symbol XBP. Until the closing of the transaction, shares will trade on Nasdaq under the symbol CFFE.

Par Chadha, Executive Chairman of Exela, indirect parent company of XBP Europe, said, “We are pleased to announce the merger agreement with CFFE following the Letter of Intent announced in late August. We continue to execute our strategy in some very difficult market conditions and look forward to communicating additional milestones.”

See Also: US Adds 263,000 Jobs In September As Labor Market Tightens: How Will The Fed Respond?

According to data from Benzinga Pro, Exela Technologies has a 52-week high of $47.60 and a 52-week low of $0.37.

Total
0
Shares
Related Posts
Read More

MediciNova Received a Notice of Allowance for a New Patent Covering MN-001 and MN-002 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Canada

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced it has received a Notice of Allowance from the Canadian Intellectual Property Office for a pending patent application which covers MN-001 (tipelu

MNOV

Read More

What’s Going On With IM Cannabis Stock?

Cannabis stocks soared Tuesday following reports that the DEA will move to reschedule marijuana from a Schedule I to a Schedule III substance. IM Cannabis shares are holding the gains, while larger weed stocks including Canopy Growth Corporation, Aurora Cannabis, Inc. and Tilray Brands, Inc. are dropping Wednesday. 

ACB